Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome

被引:30
|
作者
Sato, S
Kawashima, H
Oshiro, H
Hasegawa, D
Kashiwagi, Y
Takekuma, K
Hoshika, A
机构
[1] Tokyo Med Univ, Dept Paediat, Shinjuku Ku, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1600023, Japan
关键词
Epstein-Barr virus; hemophagocytic syndrome; tumor necrosis factor-alpha; interleukin-6; interferon-gamma;
D O I
10.1016/j.jcv.2004.06.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hemophagocytic syndrome (HPS) is caused by the hyperactivation of T-cells and macrophages. The clinical characteristics associated with this disease result from overproduction of cytokines including interferon-gamma (INF-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6). HPS presents with fever, liver dysfunction, coagulation abnormalities, pancytopenia, and a benign histiocytic proliferation with prominent hemophagocytosis in bone marrow, lymph node, spleen, and liver. We describe a 19-year-old female with fatal HPS. She had been given corticosteroid every other day for systemic lupus erythematosus (SLE) without flare Lip. The causative underlying disease was acute primary Epstein-Barr virus (EBV) infection. EBV genomes were detected by the polymerase chain reaction (PCR). To measure the virus load we use a real-time PCR assay to quantify the amount of EBV DNA in peripheral blood lymphocytes, lung, kidney, brain and liver at autopsy. Further in situ hybridisation (ISH) and immunohistochemical studies demonstrated that Epstein-Barr virus encoded small RNA (EBER) was detected in CD8(+) T-cells in bone marrow, lung, kidney, brain, liver and spleen. In each organ, mRNA levels of inflammatory cytokines (INF-gamma, TNF-alpha, IL-6) were highly detected compared with beta-Actin mRNA levels. These results Suggest that EBV-infected CD8(+) T-cells in each organ (peripheral blood lymphocytes, lung, kidney, brain and liver) may have an integral role in the pathophysiology of the HPS. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 50 条
  • [41] Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome
    Huang, Pei
    Huang, Chengshuang
    Xu, Hongbo
    Lu, Jian
    Tian, Runmei
    Wang, Zhao
    Chen, Yan
    PEDIATRICS, 2020, 145 (06)
  • [42] Characteristics of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (HLH) in European children.
    Wagner, HJS
    Beutel, K
    Schneider, ME
    Janka, GE
    BLOOD, 2005, 106 (11) : 51B - 51B
  • [43] Clinical Characteristics and Prognostic Factors of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Children
    Ma, Honghao
    Wang Tianyou
    Li, Zhang
    Lian Hongyun
    Dong, Wang
    Zhao Yunze
    Zhao Xiaoxi
    Rui, Zhang
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S22 - S23
  • [44] THE PRESENCE OF EPSTEIN-BARR-VIRUS IN MULTIPLE ORGANS IN A FATAL CASE OF VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    PRINGLE, JH
    PRIMROSE, L
    MYINT, SH
    JOURNAL OF INFECTION, 1995, 31 (02) : 159 - 160
  • [45] VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME WITH EPSTEIN-BARR-VIRUS INFECTION
    OHSHIMA, K
    KIKUCHI, M
    EGUCHI, F
    KOBARI, S
    TASAKA, H
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (06) : 519 - 522
  • [46] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN CHILDHOOD
    YATABE, Y
    MORI, N
    OKA, K
    IIJIMA, T
    SAGA, S
    TAKADA, K
    ASAI, J
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1995, 119 (05) : 409 - 417
  • [47] Sequential Quantification of Epstein-Barr Virus DNA in a Case of Epstein-Barr Virus—Associated Hemophagocytic Syndrome
    Toru Takahashi
    Eiichi Oeda
    Yutaka Sato
    Yukio Tanizawa
    International Journal of Hematology, 2002, 76 : 290 - 291
  • [48] Clinical and immunological considerations in Epstein-Barr virus-associated diseases
    Andersson, J
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, : 72 - 82
  • [49] Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
    Imashuku, S
    Kuriyama, K
    Teramura, T
    Ishii, E
    Kinugawa, N
    Kato, M
    Sako, M
    Hibi, S
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2665 - 2673
  • [50] Prevalence of Coinfection in Children With Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis
    Qin Qiang
    Xie Zhengde
    Yang Shuang
    Shen Kunling
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (02) : E45 - E48